BMS' Wound Care, Ostomy Products Drive Device Sales In Second Quarter
This article was originally published in The Gray Sheet
Executive Summary
Sales of Bristol-Myers Squibb wound care products increased 14% to $58 mil. in the second quarter making the unit the top performer within the BMS medical devices group.